Oxaliplatin, Gemcitabine and Bevacizumab in Women With Recurrent Mullerian Carcinoma

Clinical trial NCT00418093 · TERMINATED

Trial details

NCT number: NCT00418093
Sponsor: Dana-Farber Cancer Institute
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Ovarian Cancer Fallopian Tube Cancer Primary Peritoneal Cancer

Start date: 2006-09-01
Primary completion: 2011-01-01
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.